Search results for "Vaccination"


 
Results 141 - 150 of about 516 for "Vaccination".
Sort by: Relevance | Newest | Oldest

Can medical practices provide vaccine incentives?

During the COVID-19 public health emergency, clinicians and organizations can temporarily offer incentives to get people vaccinated without violating federal anti-kickback statutes if certain safeguards are met.
https://immattersacp.org/archives/2021/10/can-medical-practices-provide-vaccine-incentives.htm
1 Oct 2021

Remain vigilant this ‘twindemic’ season

The CDC is anticipating a resumption of seasonal flu activity in the U.S., but the potential effects of the COVID-19 pandemic this year remain unknown.
https://immattersacp.org/archives/2021/10/remain-vigilant-this-twindemic-season.htm
1 Oct 2021

Trying to temper a 'twindemic'

This issue addressed the upcoming flu season amid the COVID-19 pandemic, policies around mammography, and medical tourism.
https://immattersacp.org/archives/2021/10/trying-to-temper-a-twindemic.htm
1 Oct 2021

Prep and protect medical tourists to prevent tragedies

Medical tourism may have some cost benefits, but also carries risks from complications. Internists can consult with patients before they go to mitigate potential consequences.
https://immattersacp.org/archives/2021/10/prep-and-protect-medical-tourists-to-prevent-tragedies.htm
1 Oct 2021

Ventilators, pacemakers recalled; rehab device approved

This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2021/10/ventilators-pacemakers-recalled-rehab-device-approved.htm
1 Oct 2021

Study shows shingles vaccine safe in patients taking TNF inhibitors

The safety and effectiveness of live virus vaccines, such as the varicella-zoster vaccine, have been unknown in patients with inflammatory diseases who are receiving immunomodulatory therapy.
https://immattersacp.org/weekly/archives/2021/09/28/4.htm
28 Sep 2021

CDC recommendations on COVID-19 vaccine boosters, new data on vaccine effectiveness

Several groups in the U.S. are now eligible to receive a booster dose of the Pfizer-BioNTech COVID-19 vaccine at least six months after completing the initial two-dose series.
https://immattersacp.org/weekly/archives/2021/09/28/1.htm
28 Sep 2021

Research, regulators consider booster dose of COVID-19 vaccine

FDA advisors recommended boosters for older and high-risk patients. The latest COVID-19 research looked at vaccine effectiveness, remdesivir's effects, an early indicator of vaccine-induced immune thrombotic thrombocytopenia, and rates of follow-up after hospitalization.
https://immattersacp.org/weekly/archives/2021/09/21/1.htm
21 Sep 2021

Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy

The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2021/09/latest-updates-on-acps-priorities-initiatives.htm
1 Sep 2021

Result Page: Prev   10   11   12   13   14   15   16   17   18   19   Next